Company page

Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc. (Ticker: KLDO) is a public company based in the United States, with a market capitalization of approximately $4.26 billion. The company focuses on developing innovative therapies aimed at improving human health through its proprietary microbiome-based platform. Kaleido is committed to advancing its research and product pipeline to address unmet medical needs.